Prostate-specific antigen (PSA) is a protein secreted only by epithelial prostate cells, and its elevation in serum is used to detect prostate cancer in men.Elevated PSA levels are associated with prostatitis, inflammation of the prostate or benign forms of prostatic hyperplasia, making it a valuable tumor marker for prostate cancer.The use of serology-based biomarkers for the diagnosis of prostate cancer has stimulated the need for prostate-specific antigen (PSA).
Market Analysis and Insights: Global Prostate-specific Antigen (PSA) Testing Market
The global Prostate-specific Antigen (PSA) Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Prostate-specific Antigen (PSA) Testing Scope and Segment
The global Prostate-specific Antigen (PSA) Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prostate-specific Antigen (PSA) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
CLIA Method
ELISA Method
By the application, this report covers the following segments
Screening
Post-treatment Monitoring
Other
Competitive Landscape:
The Prostate-specific Antigen (PSA) Testing key manufacturers in this market include:
Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck＆Co.
Medtronic
Sanofi-Aventis SA
Market Analysis and Insights: Global Prostate-specific Antigen (PSA) Testing Market
The global Prostate-specific Antigen (PSA) Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Prostate-specific Antigen (PSA) Testing Scope and Segment
The global Prostate-specific Antigen (PSA) Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prostate-specific Antigen (PSA) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
CLIA Method
ELISA Method
By the application, this report covers the following segments
Screening
Post-treatment Monitoring
Other
Competitive Landscape:
The Prostate-specific Antigen (PSA) Testing key manufacturers in this market include:
Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck＆Co.
Medtronic
Sanofi-Aventis SA
1 Market Overview of Prostate-specific Antigen (PSA) Testing
1.1 Prostate-specific Antigen (PSA) Testing Market Overview
1.1.1 Prostate-specific Antigen (PSA) Testing Product Scope
1.1.2 Market Status and Outlook
1.2 Global Prostate-specific Antigen (PSA) Testing Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Prostate-specific Antigen (PSA) Testing Market Size by Region (2015-2026)
1.4 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Region (2015-2020)
1.5 Global Prostate-specific Antigen (PSA) Testing Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2026)
1.6.1 North America Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2026)
1.6.2 Europe Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2026)
1.6.3 China Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2026)
1.6.5 Latin America Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2026)
2 Prostate-specific Antigen (PSA) Testing Market Overview by Type
2.1 Global Prostate-specific Antigen (PSA) Testing Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Type (2015-2020)
2.3 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2021-2026)
2.4 CLIA Method
2.5 ELISA Method
3 Prostate-specific Antigen (PSA) Testing Market Overview by Application
3.1 Global Prostate-specific Antigen (PSA) Testing Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Application (2015-2020)
3.3 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2021-2026)
3.4 Screening
3.5 Post-treatment Monitoring
3.6 Other
4 Global Prostate-specific Antigen (PSA) Testing Competition Analysis by Players
4.1 Global Prostate-specific Antigen (PSA) Testing Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2019)
4.3 Date of Key Manufacturers Enter into Prostate-specific Antigen (PSA) Testing Market
4.4 Global Top Players Prostate-specific Antigen (PSA) Testing Headquarters and Area Served
4.5 Key Players Prostate-specific Antigen (PSA) Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Prostate-specific Antigen (PSA) Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business and Company’s Total Revenue
5.1.3 Abbott Products, Services and Solutions
5.1.4 Abbott Revenue (US$ Million) (2015-2020)
5.1.5 Abbott Recent Development and Reaction to Covid-19
5.2 Boston Scientific Corporation
5.2.1 Boston Scientific Corporation Profile
5.2.2 Boston Scientific Corporation Main Business and Company’s Total Revenue
5.2.3 Boston Scientific Corporation Products, Services and Solutions
5.2.4 Boston Scientific Corporation Revenue (US$ Million) (2015-2020)
5.2.5 Boston Scientific Corporation Recent Development and Reaction to Covid-19
5.3 Bayer AG
5.5.1 Bayer AG Profile
5.3.2 Bayer AG Main Business and Company’s Total Revenue
5.3.3 Bayer AG Products, Services and Solutions
5.3.4 Bayer AG Revenue (US$ Million) (2015-2020)
5.3.5 Siemens Healthcare Recent Development and Reaction to Covid-19
5.4 Siemens Healthcare
5.4.1 Siemens Healthcare Profile
5.4.2 Siemens Healthcare Main Business and Company’s Total Revenue
5.4.3 Siemens Healthcare Products, Services and Solutions
5.4.4 Siemens Healthcare Revenue (US$ Million) (2015-2020)
5.4.5 Siemens Healthcare Recent Development and Reaction to Covid-19
5.5 DiaSorin
5.5.1 DiaSorin Profile
5.5.2 DiaSorin Main Business and Company’s Total Revenue
5.5.3 DiaSorin Products, Services and Solutions
5.5.4 DiaSorin Revenue (US$ Million) (2015-2020)
5.5.5 DiaSorin Recent Development and Reaction to Covid-19
5.6 Roche
5.6.1 Roche Profile
5.6.2 Roche Main Business and Company’s Total Revenue
5.6.3 Roche Products, Services and Solutions
5.6.4 Roche Revenue (US$ Million) (2015-2020)
5.6.5 Roche Recent Development and Reaction to Covid-19
5.7 Beckman Coulter
5.7.1 Beckman Coulter Profile
5.7.2 Beckman Coulter Main Business and Company’s Total Revenue
5.7.3 Beckman Coulter Products, Services and Solutions
5.7.4 Beckman Coulter Revenue (US$ Million) (2015-2020)
5.7.5 Beckman Coulter Recent Development and Reaction to Covid-19
5.8 PerkinElmer
5.8.1 PerkinElmer Profile
5.8.2 PerkinElmer Main Business and Company’s Total Revenue
5.8.3 PerkinElmer Products, Services and Solutions
5.8.4 PerkinElmer Revenue (US$ Million) (2015-2020)
5.8.5 PerkinElmer Recent Development and Reaction to Covid-19
5.9 Tosoh
5.9.1 Tosoh Profile
5.9.2 Tosoh Main Business and Company’s Total Revenue
5.9.3 Tosoh Products, Services and Solutions
5.9.4 Tosoh Revenue (US$ Million) (2015-2020)
5.9.5 Tosoh Recent Development and Reaction to Covid-19
5.10 Ortho Clinical
5.10.1 Ortho Clinical Profile
5.10.2 Ortho Clinical Main Business and Company’s Total Revenue
5.10.3 Ortho Clinical Products, Services and Solutions
5.10.4 Ortho Clinical Revenue (US$ Million) (2015-2020)
5.10.5 Ortho Clinical Recent Development and Reaction to Covid-19
5.11 Fujirebio
5.11.1 Fujirebio Profile
5.11.2 Fujirebio Main Business and Company’s Total Revenue
5.11.3 Fujirebio Products, Services and Solutions
5.11.4 Fujirebio Revenue (US$ Million) (2015-2020)
5.11.5 Fujirebio Recent Development and Reaction to Covid-19
5.12 Mediwatch
5.12.1 Mediwatch Profile
5.12.2 Mediwatch Main Business and Company’s Total Revenue
5.12.3 Mediwatch Products, Services and Solutions
5.12.4 Mediwatch Revenue (US$ Million) (2015-2020)
5.12.5 Mediwatch Recent Development and Reaction to Covid-19
5.13 BodiTech
5.13.1 BodiTech Profile
5.13.2 BodiTech Main Business and Company’s Total Revenue
5.13.3 BodiTech Products, Services and Solutions
5.13.4 BodiTech Revenue (US$ Million) (2015-2020)
5.13.5 BodiTech Recent Development and Reaction to Covid-19
5.14 Bristol-Myers Squibb Company
5.14.1 Bristol-Myers Squibb Company Profile
5.14.2 Bristol-Myers Squibb Company Main Business and Company’s Total Revenue
5.14.3 Bristol-Myers Squibb Company Products, Services and Solutions
5.14.4 Bristol-Myers Squibb Company Revenue (US$ Million) (2015-2020)
5.14.5 Bristol-Myers Squibb Company Recent Development and Reaction to Covid-19
5.15 GE Healthcare
5.15.1 GE Healthcare Profile
5.15.2 GE Healthcare Main Business and Company’s Total Revenue
5.15.3 GE Healthcare Products, Services and Solutions
5.15.4 GE Healthcare Revenue (US$ Million) (2015-2020)
5.15.5 GE Healthcare Recent Development and Reaction to Covid-19
5.16 Endocare
5.16.1 Endocare Profile
5.16.2 Endocare Main Business and Company’s Total Revenue
5.16.3 Endocare Products, Services and Solutions
5.16.4 Endocare Revenue (US$ Million) (2015-2020)
5.16.5 Endocare Recent Development and Reaction to Covid-19
5.17 Merck＆Co.
5.17.1 Merck＆Co. Profile
5.17.2 Merck＆Co. Main Business and Company’s Total Revenue
5.17.3 Merck＆Co. Products, Services and Solutions
5.17.4 Merck＆Co. Revenue (US$ Million) (2015-2020)
5.17.5 Merck＆Co. Recent Development and Reaction to Covid-19
5.18 Medtronic
5.18.1 Medtronic Profile
5.18.2 Medtronic Main Business and Company’s Total Revenue
5.18.3 Medtronic Products, Services and Solutions
5.18.4 Medtronic Revenue (US$ Million) (2015-2020)
5.18.5 Medtronic Recent Development and Reaction to Covid-19
5.19 Sanofi-Aventis SA
5.19.1 Sanofi-Aventis SA Profile
5.19.2 Sanofi-Aventis SA Main Business and Company’s Total Revenue
5.19.3 Sanofi-Aventis SA Products, Services and Solutions
5.19.4 Sanofi-Aventis SA Revenue (US$ Million) (2015-2020)
5.19.5 Sanofi-Aventis SA Recent Development and Reaction to Covid-19
6 North America Prostate-specific Antigen (PSA) Testing by Players and by Application
6.1 North America Prostate-specific Antigen (PSA) Testing Market Size and Market Share by Players (2015-2020)
6.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
7 Europe Prostate-specific Antigen (PSA) Testing by Players and by Application
7.1 Europe Prostate-specific Antigen (PSA) Testing Market Size and Market Share by Players (2015-2020)
7.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
8 China Prostate-specific Antigen (PSA) Testing by Players and by Application
8.1 China Prostate-specific Antigen (PSA) Testing Market Size and Market Share by Players (2015-2020)
8.2 China Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
9 Rest of Asia Pacific Prostate-specific Antigen (PSA) Testing by Players and by Application
9.1 Rest of Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
10 Latin America Prostate-specific Antigen (PSA) Testing by Players and by Application
10.1 Latin America Prostate-specific Antigen (PSA) Testing Market Size and Market Share by Players (2015-2020)
10.2 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
11 Middle East & Africa Prostate-specific Antigen (PSA) Testing by Players and by Application
11.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
12 Prostate-specific Antigen (PSA) Testing Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
